Search Results

You searched for : Immixbio

	ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma Latest pharma news update... Oct 04
	ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors Latest Pharma News Update... Aug 31
2 Matching result(s) found!

-Advertisements-

Trending Now
	Seminar on RERA: Concerns in Real Estate heldDecember 09, 2023
	Commonwealth youth leaders want action, not just rhetoric at COP28December 09, 2023
	South India’s biggest Gaushala, Satyam Shivam Sundaram Gau Nivas to conduct Annakut Celebrations on Sunday on the eve of its 23rd AnniversaryDecember 08, 2023
	Center for Diagnostics and Telemedicine Introduces Groundbreaking Service – Preliminary Clinical and Technical Testing for Medical SoftwareDecember 08, 2023
	FTCCI to hold a Seminar on RERA: Concerns in Real EstateDecember 08, 2023
	Adoption of Public Health Strategies and Early Detection Key for Cancer Mitigation: ExpertsDecember 08, 2023
	Are online spaces safe for women?December 08, 2023
	Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023
	Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023
	Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
	Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023
	Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023
	Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
	Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
	IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
	Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023
	Madras High Court Advocates for Equality: PG Medical Students to Receive Incentive Marks for COVID-19 DutyNovember 18, 2023
	Next-Gen Healthcare: CarePods and AI Redefine the Patient ExperienceNovember 17, 2023
	Air Quality Crisis: Alarming Rise in Premature Births Linked to Air Quality in Begusarai, BiharNovember 17, 2023
	Limerick Contest-2023: A Celebration of Wit and PoetryNovember 17, 2023

Search Results

ImmixBio announces FDA Orphan drug designation for IMX-110 for the treatment of Soft Tissue Sarcoma

ImmixBio and BeiGene to evaluate combination of IMX-110 and Tislelizumab in solid tumors

Trending Now